SCI时时刷

search
Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer
The aim of the current research was to investigate the prognostic significance of pretreatment hemoglobin-to-red cell dist...
Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer
Aim: To estimate the cost-savings from conversion to biosimilar pegfilgrastim-cbqv that can be reallocated to provide budg...
OLIE, ITCC-082: a Phase II trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma
While survival rates for patients with relapsed/refractory osteosarcoma are low, kinase inhibitors have shown efficacy in ...
Understanding patient factors to increase uptake of cancer screening: a review
Early detection of cancer through organized screening is a central component of population-level strategies to reduce canc...
What is the role of real-world data in metastatic renal cell cancer?
K Fife is affiliated with the Urological Malignancies Programme, CRUK Cambridge Centre. She has received advisory, consult...
Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma
Aims: Individualized patient profiling is instrumental for personalized management in hepatocellular carcinoma (HCC). This...
A robust ferroptosis-related gene signature predicts overall survival in clear cell renal cell carcinoma
Aims: To investigate the prognostic values and potential mechanisms of ferroptosis-related genes in clear cell renal cell ...
The future of oncology care requires integration of patient engagement and equity into practice
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial intere...
Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy
Aim: To evaluate the prognostic value of the lymph node ratio (LNR) and other clinicopathological factors in patients with...
An interview with Ginny Mason: 20 years of kicking butt and taking names
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial intere...
An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is the most complex, aggressive and fatal subtype of breast cancer. Owing to the lack...
Risk of arterial and venous thromboembolic events among patients with colorectal carcinoma: a real-world, population-based study
Objective: To assess real-world patterns of arterial and venous thromboembolism among patients with colorectal carcinoma. ...
Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain
Aim: To describe treatment patterns and outcomes in nontransplant newly diagnosed multiple myeloma (NDMM) patients in Spai...
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy
Aim: To evaluate the immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic ...
Hyperthermic intrathoracic chemotherapy in thoracic surgical oncology: future challenges of an exciting procedure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial intere...
Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy
Background: A malignant tumor's immune environment, including infiltrating immune cell status, can be critical to patient ...
A concise prognostic score system for diffuse large B-cell lymphoma: a retrospective study with long-term follow-up
Aim: To identify risk factors and establish a concise prognostic scoring system in patients with diffuse large B-cell lymp...
Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapy
Aim: To investigate real-world overall survival (rwOS) and real-world progression-free survival (rwPFS) in locally advance...
Prognostic significance and function of MCM10 in human hepatocellular carcinoma
Aim: To investigate the role of MCM10, a conserved replication factor, in hepatocellular carcinoma (HCC). Methods: We used...
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challenges
Lung cancer continues to be the leading cause of cancer mortality and a serious health problem despite the numerous advanc...
Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey
Aims: This paper reports the results of a survey assessing the acceptance of the coronavirus disease 2019 (COVID-19) vacci...
Pragmatic patient engagement in designing pragmatic oncology clinical trials
Oncology trials are the cornerstone of effective and safe therapeutic discoveries. However, there is increasing demand for...
Identification of Notch signaling pathway gene mutations as a prognostic biomarker for bladder cancer
Purpose: The authors aimed to identify Notch signaling pathway gene mutations as a prognostic biomarker for bladder cancer...
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer
Aim: To evaluate the efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metasta...
Patient preferences for advanced hepatocellular carcinoma treatment: a multicountry stated preference study
The present study aimed to explore patient preferences for attributes of advanced hepatocellular carcinoma (HCC) treatment...
Bone metastases and hepatocellular carcinoma: some food for thought
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial intere...
Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencing
The aim of the present study was to determine cell of origin (COO) from a platform using a DNA-based method, COO DNA class...
Oligometastatic prostate cancer treatment
Oligometastatic prostate cancer is an intermediate state between localized disease and widespread metastasis. Its biologic...